Fundamental scientific research is often a long, arduous, and trying road—from the discovery of new mechanisms or laws, to the intense research into the details, and finally publishing the results and applications.
Prof. Tasuku Honjo is one of the pioneers in the field of cancer immunotherapy and genetic research in Japan. In 1992, he made a breakthrough discovery of the PD-1 receptor; and then discovered its function as a “brake” on the immune system. By releasing this brake, he found, the human immune response could be heightened. But it was only after a long road of basic, day-in and day-out research that he was able to apply his discovery to cancer immunotherapy.
In recognition of such a paradigm shifting contribution to medicine, Prof. Tasuku Honjo and Dr. James P. Allison were announced as the joint recipients of the first Tang Prize in Biopharmaceutical Science in 2014.
We welcome you to listen to this learned scientist and philosopher at his lecture on June 29, titled “Perseverance—Tang Prize Laureate Tasuku Honjo and his Research in Cancer Immunotherapy,” hosted by PanSci and Commonwealth Magazine. Listen to him talk about his early years as a high school student who, in his own words, “wanted to help as many people as possible,” his outlook on philosophy and humanity, and his over 50 years of experience in immunotherapy research, a new medical discipline that has helped the lives of countless individuals.
Time: 2015/06/29 (Mon) 14:00-17:00
Venue: B1, Building 1 College of Management, NTU Zhengda Auditorium
(National Taiwan University No. 85, Section 4, Roosevelt Rd, Da’an District, Taipei City, 106; MRT Gongguan Station, Exit 2)
Notes: Event run in English
14:00 ~ 15:00 Sign-in at event
15:00 ~ 15:10 Opening words from Tang prize CEO Dr. Jenn-Chuan Chern
15:10 ~ 15:40 Lecture from Prof. Tasuku Honjo
15:40 ~ 16:15 Discussion between Prof. Honjo and PanSci guest speakers
16:15 ~ 16:40 Open Q&A
16:40 ~ 17:10 Book Signing